Circulating Brain-Derived Neurotrophic Factor Has Diagnostic and Prognostic Value in Traumatic Brain Injury
Frederick K. Korley(University of California, San Francisco), David M. Schnyer(The University of Texas at Austin), Hester F. Lingsma(Erasmus MC), Ramon Diaz‐Arrastia(University of Antwerp), Pratik Mukherjee(University of California, San Francisco), Esther L. Yuh(University of California, San Francisco), Allen D. Everett(Johns Hopkins University), Ava M. Puccio(University of Pittsburgh Medical Center), Alex B. Valadka(Central Texas Spine Institute), Haris I. Sair(Johns Hopkins University), Alan H.B. Wu(San Francisco General Hospital), John K. Yue(San Francisco General Hospital), Wayne A. Gordon(Icahn School of Medicine at Mount Sinai), Geoffrey T. Manley(University of Antwerp), Jennifer E. Van Eyk, Andrew I.R. Maas(University of California, San Francisco), David O. Okonkwo(University of Pittsburgh)
Cited by 152
Related Papers
Traumatic brain injury: progress and challenges in prevention, clinical care, and research
|The Lancet Neurology|2022|1.3k
How many human proteoforms are there?
|Nature Chemical Biology|2018|942
Blood GFAP as an emerging biomarker in brain and spinal cord disorders
|Nature Reviews Neurology|2022|809